[ESPR] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -162.05%
YoY- -18.57%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 18,841 40,659 212,236 982 0 0 0 -
PBT -66,324 -43,668 124,611 -54,221 -45,730 -43,337 -14,035 29.52%
Tax 13,948 11,153 4,721 0 0 433 494 74.45%
NP -80,272 -43,668 124,611 -54,221 -45,730 -43,337 -14,035 33.71%
Tax Rate - - -3.79% - - - - -
Total Cost 99,113 84,327 87,625 55,203 45,730 43,337 14,035 38.49%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -426.05 -107.40 58.71 -5,521.49 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -1.27 -1.67 4.50 -2.01 -1.71 -1.92 -0.62 12.68%
EPS Diluted -1.27 -1.67 4.32 -2.01 -1.71 -1.92 -0.62 12.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.